mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
BIBW2992 |
FIMM |
pan-cancer |
AAC |
0.27 |
0.09 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.09 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |